Literature DB >> 6809476

Influence of low doses of naloxone on pituitary secretion in man.

E Rolandi, A Marabini, G Magnani, A Sannia, T Barreca.   

Abstract

Naloxone 0.8 mg im administered to eight healthy subjects did not affect the serum levels of GH, LH, FSH, PRL, TSH and cortisol. Pretreatment with naloxone 0.8 mg increased TRH-induced TSH and PRL release in six healthy subjects. The same pretreatment caused an enhancement of haloperidol-induced PRL secretion in further other group of six subjects.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6809476     DOI： 10.1007/BF00545217

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  22 in total

1.  Relation of endogenous opioid peptides and morphine to neuroendocrine functions.

Authors:  J Meites; J F Bruni; D A Van Vugt; A F Smith
Journal:  Life Sci       Date:  1979-04-09       Impact factor: 5.037

2.  Naloxone increases ACTH and cortisol levels in man.

Authors:  J Volavka; D Cho; A Mallya; J Bauman
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

3.  A radioimmunoassay for cortisol in plasma and urine.

Authors:  H J Ruder; R L Guy; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

4.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

5.  Radioimmunoassay of human growth hormone.

Authors:  G M Molinatti; F Massara; E Strumia; F Pennisi; G A Scassellati; L Vancheri
Journal:  J Nucl Biol Med       Date:  1969 Jan-Jun

6.  Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.

Authors:  I J Spiler; M E Molitch
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

7.  Endocrine effects of naloxone-induced opiate receptor blockade.

Authors:  J E Morley; N G Baranetsky; T D Wingert; H E Carlson; J M Hershman; S Melmed; S R Levin; K R Jamison; R Weitzman; R J Chang; A A Varner
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

8.  Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.

Authors:  I Wakabayashi; R Demura; N Miki; E Ohmura; H Miyoshi; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

9.  Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.

Authors:  M E Quigley; K L Sheehan; R F Casper; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

10.  The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.

Authors:  A Grossman; P J Moult; R C Gaillard; G Delitala; W D Toff; L H Rees; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478
View more
  1 in total

1.  Serum concentrations of PRL, GH, LH, FSH, TSH and cortisol after single administration to man of a new synthetic narcotic analgesic butorphanol.

Authors:  E Rolandi; R Franceschini; A Marabini; V Messina; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.